Orthofix Medical, Inc. (OFIX)
9.29
-0.02
(-0.21%)
USD |
NASDAQ |
Sep 04, 16:00
9.275
-0.02
(-0.16%)
After-Hours: 20:00
Orthofix Medical Research and Development Expense (Quarterly) : 14.86M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.86M |
| March 31, 2026 | 15.32M |
| December 31, 2025 | 15.37M |
| September 30, 2025 | 14.77M |
| June 30, 2025 | 15.93M |
| March 31, 2025 | 19.77M |
| December 31, 2024 | 18.81M |
| September 30, 2024 | 17.29M |
| June 30, 2024 | 18.05M |
| March 31, 2024 | 19.49M |
| December 31, 2023 | 18.94M |
| September 30, 2023 | 18.56M |
| June 30, 2023 | 19.42M |
| March 31, 2023 | 23.31M |
| December 31, 2022 | 13.15M |
| September 30, 2022 | 11.94M |
| June 30, 2022 | 12.76M |
| March 31, 2022 | 11.21M |
| December 31, 2021 | 13.24M |
| September 30, 2021 | 12.36M |
| June 30, 2021 | 13.62M |
| March 31, 2021 | 11.90M |
| December 31, 2020 | 10.36M |
| September 30, 2020 | 9.962M |
| June 30, 2020 | 8.765M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.964M |
| December 31, 2019 | 8.446M |
| September 30, 2019 | 7.982M |
| June 30, 2019 | 8.98M |
| March 31, 2019 | 9.229M |
| December 31, 2018 | 8.792M |
| September 30, 2018 | 9.598M |
| June 30, 2018 | 7.891M |
| March 31, 2018 | 6.937M |
| December 31, 2017 | 8.454M |
| September 30, 2017 | 6.935M |
| June 30, 2017 | 6.887M |
| March 31, 2017 | 7.424M |
| December 31, 2016 | 7.509M |
| September 30, 2016 | 6.858M |
| June 30, 2016 | 6.796M |
| March 31, 2016 | 7.636M |
| December 31, 2015 | 7.57M |
| September 30, 2015 | 6.523M |
| June 30, 2015 | 6.451M |
| March 31, 2015 | 5.845M |
| December 31, 2014 | 6.176M |
| September 30, 2014 | 6.572M |
| June 30, 2014 | 6.313M |
| March 31, 2014 | 5.933M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Accuray, Inc. | 7.707M |
| Micron Solutions, Inc. | -- |
| ResMed, Inc. | 105.73M |
| Rockwell Medical, Inc. | 0.04M |
| Microbot Medical, Inc. | 1.846M |